文献速递精神分裂症与精神病性障碍

精神分裂症中的糖基化异常:25年尸脑研究综述

Aberrant glycosylation in schizophrenia: a review of 25 years of post-mortem brain studies.
PubMed 文献 · Mol Psychiatry · 2020-05-13

本文综述了25年来分析死后脑样本的研究,发现精神分裂症个体存在糖基化异常。兴奋性与抑制性神经传递相关蛋白显示糖链改变,PSA-NCAM与周围神经网在多个脑区下调,糖合成通路酶表达存在差异。全基因组关联研究将多个糖基化酶与精神分裂症关联,提示糖基化在疾病中的重要性。

要点

  • 精神分裂症死后脑中兴奋性与抑制性神经传递蛋白的糖链修饰发生改变。
  • PSA-NCAM与周围神经网在精神分裂症多个脑区下调。
  • 糖基化改变可能源于遗传、环境、用药或其组合,需进一步研究。

核心结论

  • 精神分裂症个体死后脑样本存在糖基化异常,涉及神经传递蛋白、PSA-NCAM、周围神经网及糖合成酶。
  • 全基因组关联研究将多个糖基化酶与精神分裂症关联,提示糖基化在疾病发病机制中的重要性。

研究设计与样本

  • 综述分析了过去25年关于精神分裂症死后脑样本糖基化的研究。
  • 研究类型为对死后脑样本的分析性研究汇总。

主要发现

  • 兴奋性与抑制性神经传递相关蛋白在疾病状态下显示糖链改变,包括AMPA和红藻氨酸受体亚基、谷氨酸转运体EAAT1和EAAT2及GABAA受体。
  • PSA-NCAM和周围神经网在精神分裂症个体多个脑区下调。
  • 多个糖合成通路的酶在精神分裂症脑中显示差异表达。
  • 糖基化改变可能由遗传易感性、环境扰动、药物使用或其组合导致。

临床怎么用

  • 理解糖基化失调有助于认识精神分裂症的发育与病理生理机制。
  • 糖基化相关酶与精神分裂症的遗传关联提示其作为潜在研究靶点的价值。

局限性

  • 糖基化改变的原因(遗传、环境、药物或其组合)尚不明确。
  • 综述基于死后脑样本研究,无法确定因果方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Glycosylation, the enzymatic attachment of carbohydrates to proteins and lipids, regulates nearly all cellular processes and is critical in the development and function of the nervous system. Axon pathfinding, neurite outgrowth, synaptogenesis, neurotransmission, and many other neuronal processes are regulated by glycans. Over the past 25 years, studies analyzing post-mortem brain samples have found evidence of aberrant glycosylation in individuals with schizophrenia. Proteins involved in both excitatory and inhibitory neurotransmission display altered glycans in the disease state, including AMPA and kainate receptor subunits, glutamate transporters EAAT1 and EAAT2, and the GABAA receptor. Polysialylated NCAM (PSA-NCAM) and perineuronal nets, highly glycosylated molecules critical for axonal migration and synaptic stabilization, are both downregulated in multiple brain regions of individuals with schizophrenia. In addition, enzymes spanning several pathways of glycan synthesis show differential expression in brains of individuals with schizophrenia. These changes may be due to genetic predisposition, environmental perturbations, medication use, or a combination of these factors. However, the recent association of several enzymes of glycosylation with schizophrenia by genome-wide association studies underscores the importance of glycosylation in this disease. Understanding how glycosylation is dysregulated in the brain will further our understanding of how this pathway contributes to the development and pathophysiology of schizophrenia.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Williams SE, Mealer RG, Scolnick EM, et al. Aberrant glycosylation in schizophrenia: a review of 25 years of post-mortem brain studies. Mol Psychiatry. 2020. PMID: 32404945. doi:10.1038/s41380-020-0761-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。